NOBLAZIN

This brand name is authorized in Turkey.

Active ingredients

The drug NOBLAZIN contains one active pharmaceutical ingredient (API):

`1`	Lidoflazine UNII `J4ZHN3HBTE` - LIDOFLAZINE
	Read more about Lidoflazine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08EX01	Lidoflazine	C Cardiovascular system → C08 Calcium channel blockers → C08E Non-selective calcium channel blockers → C08EX Other non-selective calcium channel blockers
Discover more medicines within C08EX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
TR	İlaç ve Tıbbi Cihaz Kurumu	8699540013407, 8699540013414, 8699540013421

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.